Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

NSF Awards U.S. Genomics a $500K Phase II-B SBIR Grant

Published: Friday, October 07, 2005
Last Updated: Friday, October 07, 2005
Bookmark and Share
The $500,000 grant is earmarked for development of a commercial platform that uses the Company's rapid DNA analysis and genomic mapping technologies.

U.S. Genomics, Inc. has announced that it has received a Phase II-B SBIR grant from the National Science Foundation.

The $500,000 grant is earmarked for development of a commercial platform that uses the Company's rapid DNA analysis and genomic mapping technologies. 

U.S. Genomics plans to use this installment to develop its Substance Identification and Quantitation Using Molecular Barcodes (SIQUMB) technology.

“This additional SBIR award recognizes the achievements we've made in developing single molecule analysis and genomic mapping for commercialization,” said John J. Canepa, acting Chief Executive Officer of U.S. Genomics. 

“The ability to acquire and analyze molecular information has been made much more efficient with the invention of the SIQUMB molecular identification process.”

“This technology will be valuable for many commercial applications in life science research and in the healthcare industry.”

In July 2002, U.S. Genomics was awarded Phase I of the SBIR grant to create genomic maps by tagging and stretching individual DNA molecules.

During the Phase I project, U.S. Genomics achieved fundamental milestones by mapping long DNA molecules and substantially increasing the throughput and accuracy of the mapping technology.

In August 2003, the Company earned the subsequent Phase II grant.  As part of the Phase II application, researchers at U.S. Genomics enhanced the capabilities of the DNA mapping platform and invented SIQUMB.

The recent award will enable U.S. Genomics to continue its development and commercialization of the SIQUMB technology.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

U.S. Genomics Announces Recipient of Outstanding Investigator in Single Molecule Biology Award
Dr. James A. Spudich will be presented the award at the 50th Annual Meeting of the Biophysical Society.
Tuesday, February 21, 2006
U.S. Genomics Announces New Chief Executive Officer
John J. Canepa has been promoted to President, CEO and member of the Board of Directors.
Friday, December 16, 2005
U.S. Genomics Expands its Efforts With New VP
U.S. Genomics Names Duncan Whitney as Vice President of Research and Development.
Friday, September 30, 2005
Scientific News
Genetic Cause of Rare Allergy
Institute has identified a genetic mutation responsible for a rare form of inherited hives induced by vibratory urticaria.
Mitochondria Shown to Trigger Cell Ageing
An international team of scientists has for the first time shown that mitochondria, the batteries of the cells, are essential for ageing.
Cancer Cells Kill Off Healthy Neighbours
Cancer cells create space to grow by killing off surrounding healthy cells, according to UK researchers working with fruit flies.
Validating the Accuracy of CRISPR-Cas9
IBS Researchers create multiplex Digenome-seq to find errors in CRISPR-Cas9 processes.
Cancer Drug Target Visualized at Atomic Resolution
New study using cryo-electron microscopy shows how potential drugs could inhibit cancer.
Genetic Mechanism Behind Cancer-Causing Mutations
Researchers at Indiana University has identified a genetic mechanism that is likely to drive mutations that can lead to cancer.
"Gene Fusion" Drives Childhood Brain Cancers
Study co-led by Penn scientists highlights potential targets for future cancer therapies.
Enzyme Links Age-Related Inflammation, Cancer
Researchers have shown that an enzyme key to regulating gene expression -- and also an oncogene when mutated -- is critical for the expression of numerous inflammatory compounds that have been implicated in age-related increases in cancer and tissue degeneration.
How to Unlock Inaccessible Genes
An international team of biologists has discovered how specialized enzymes remodel the extremely condensed genetic material in the nucleus of cells in order to control which genes can be used.
Viral Gene Editing System Corrects Genetic Liver Disease
Penn study has implications for developing safe therapies for an array of rare diseases via new gene cut-and-paste methods.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!